After that, the expression levels of six PANoptosis-related genes were quantified, as the heatmap showcased that SRC, DAPK2 and NR4A2 were primarily up-regulated in low-risk BC patients, while other three PANoptosis genes had higher expression levels in other risk patients (Figure 7D). Here, DAPK2 is linked to breast cancer.